Matches in Wikidata for { <http://www.wikidata.org/entity/Q91086003> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- Q91086003 description "article scientifique publié en 2019" @default.
- Q91086003 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91086003 description "scientific article published on 19 November 2019" @default.
- Q91086003 description "wetenschappelijk artikel" @default.
- Q91086003 description "наукова стаття, опублікована 19 листопада 2019" @default.
- Q91086003 description "գիտական հոդված հրատարակված 2019 թվականի նոյեմբերի 19-ին" @default.
- Q91086003 name "The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival" @default.
- Q91086003 name "The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival" @default.
- Q91086003 type Item @default.
- Q91086003 label "The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival" @default.
- Q91086003 label "The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival" @default.
- Q91086003 prefLabel "The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival" @default.
- Q91086003 prefLabel "The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival" @default.
- Q91086003 P1433 Q91086003-20048BAA-C6A1-428A-95D8-2F1F5AC7465C @default.
- Q91086003 P1476 Q91086003-DA3CC3A5-034B-4F08-BFA3-C6AC7C8D408D @default.
- Q91086003 P2093 Q91086003-36E8580A-638E-4796-BBE0-87DABD62C0E5 @default.
- Q91086003 P2093 Q91086003-56351A2D-4807-4049-B982-A72EDE85E8F2 @default.
- Q91086003 P2093 Q91086003-7AAD6B19-2793-46C0-8BEB-08FFEADF5EA3 @default.
- Q91086003 P2093 Q91086003-C1AC3631-2109-4483-8F8D-5AD451DD3437 @default.
- Q91086003 P304 Q91086003-574E1DEA-E901-4077-9535-E71BC41DD35E @default.
- Q91086003 P31 Q91086003-7CD1774D-9D9F-4D55-ACB9-46B5F9FF5B93 @default.
- Q91086003 P356 Q91086003-C04A6C6B-876C-4647-9321-3F4B72A24081 @default.
- Q91086003 P433 Q91086003-A91DF0BC-789F-45F7-A817-34474370DD41 @default.
- Q91086003 P478 Q91086003-E960B7CB-D584-4D2C-98F0-AC6EAA020A89 @default.
- Q91086003 P50 Q91086003-0471DFA1-7B69-41E0-8EC8-68136C36C246 @default.
- Q91086003 P50 Q91086003-0CBD94F4-5ADE-4401-A191-12CF6F831B29 @default.
- Q91086003 P50 Q91086003-0F9015C1-118C-4CB3-88FE-4594968633AB @default.
- Q91086003 P50 Q91086003-297B01E4-7D7C-44B9-9845-FC706E9DE35F @default.
- Q91086003 P50 Q91086003-29E80271-DD00-4C18-B2C5-22031D4F3F9D @default.
- Q91086003 P50 Q91086003-2DA49A85-72A3-427B-A65E-90547714D216 @default.
- Q91086003 P50 Q91086003-44C78094-BD9D-402B-8661-6123EE8BE1EA @default.
- Q91086003 P50 Q91086003-5BD58567-3E67-456F-85D7-C334BD2834FC @default.
- Q91086003 P50 Q91086003-68C9D90B-435D-45F8-AFCE-B38447373FAC @default.
- Q91086003 P50 Q91086003-6E5080EC-207A-4972-9BEB-D0DA1044825B @default.
- Q91086003 P50 Q91086003-7821E8A9-A3DB-49CA-B28D-AE41A72D0014 @default.
- Q91086003 P50 Q91086003-8BFE23A1-BEDC-4027-B98F-31E65E8D9CF5 @default.
- Q91086003 P50 Q91086003-95782B0C-8E75-4CFE-998F-ABA8C1E08582 @default.
- Q91086003 P50 Q91086003-967E3878-0998-4E8A-A904-D5E114077B2D @default.
- Q91086003 P50 Q91086003-9721F3D0-F5D0-4077-890B-9E07048392AB @default.
- Q91086003 P50 Q91086003-9EED5408-DBD9-4491-B1CB-7CF83F04403F @default.
- Q91086003 P50 Q91086003-BB671903-47B3-447C-9B3F-97D28B7F092C @default.
- Q91086003 P50 Q91086003-C66F2699-107C-4887-8955-4E026335D359 @default.
- Q91086003 P50 Q91086003-ECAB5E53-14CB-4F60-AD6F-3E9D38AF2AD2 @default.
- Q91086003 P577 Q91086003-4AA41BAB-2200-43D1-ABA7-282835BE7B80 @default.
- Q91086003 P698 Q91086003-8631F3C0-39D3-40E0-A473-548538DAF0CD @default.
- Q91086003 P921 Q91086003-0741C8BD-3897-4BF5-8BD2-0C379B862E2E @default.
- Q91086003 P356 AJH.25671 @default.
- Q91086003 P698 31682008 @default.
- Q91086003 P1433 Q4744246 @default.
- Q91086003 P1476 "The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival" @default.
- Q91086003 P2093 "Farhad Ravandi" @default.
- Q91086003 P2093 "Nitin Jain" @default.
- Q91086003 P2093 "Sherry Pierce" @default.
- Q91086003 P2093 "Xuemei Wang" @default.
- Q91086003 P304 "144-150" @default.
- Q91086003 P31 Q13442814 @default.
- Q91086003 P356 "10.1002/AJH.25671" @default.
- Q91086003 P433 "2" @default.
- Q91086003 P478 "95" @default.
- Q91086003 P50 Q108918871 @default.
- Q91086003 P50 Q114427906 @default.
- Q91086003 P50 Q42365103 @default.
- Q91086003 P50 Q43242254 @default.
- Q91086003 P50 Q57166181 @default.
- Q91086003 P50 Q60320900 @default.
- Q91086003 P50 Q60394812 @default.
- Q91086003 P50 Q61095385 @default.
- Q91086003 P50 Q63852514 @default.
- Q91086003 P50 Q64026278 @default.
- Q91086003 P50 Q64026337 @default.
- Q91086003 P50 Q64026418 @default.
- Q91086003 P50 Q66370727 @default.
- Q91086003 P50 Q66385413 @default.
- Q91086003 P50 Q87641766 @default.
- Q91086003 P50 Q87653316 @default.
- Q91086003 P50 Q88053364 @default.
- Q91086003 P50 Q88337925 @default.
- Q91086003 P50 Q89564940 @default.
- Q91086003 P577 "2019-11-19T00:00:00Z" @default.
- Q91086003 P698 "31682008" @default.
- Q91086003 P921 Q102293395 @default.